GTS Securities’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRE
GTS Securities's SYRE Position: Q3 2026 in Review
GTS Securities opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 3,291 shares worth $293K. The stake represents 0.01% of the portfolio and ranks #1247 among its holdings.
286 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.
- GTS Securities held 3,291 shares of Spyre Therapeutics worth $293K as of Q3 2026.
- Spyre Therapeutics was a new GTS Securities position in Q3 2026.
- Spyre Therapeutics made up 0.01% of GTS Securities's portfolio in Q3 2026, its #1247 holding.
- 286 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.